Associate Professor, Radiology, Boston University School of Medicine
Radiation Oncology
Dr. Timothy D. Shafman, MD
|
|
Give Review
Timothy Shafman works in the field of Radiation Oncology. He attended Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He received awards:"CMS Meaningful Use Stage 1 Certification". Timothy Shafman is also published. He has 44 publications published. The lastest publication: "Interaction between ATM protein and c-Abl in response to DNA damage.' Timothy Shafman accepts all Medicare patients.
Publications
- Current status of immunotherapy and gene therapy for high-grade gliomas.
- The utility of non-axial treatment beam orientations for lower lobe lung cancers.
- Assessing the ability of the antiangiogenic and anticytokine agent thalidomide to modulate radiation-induced lung injury.
- Combination chemotherapy and radiation therapy for upper aerodigestive tract cancers.
- "Anatomically-correct" dosimetric parameters may be better predictors for esophageal toxicity than are traditional CT-based metrics.
- Challenges in defining radiation pneumonitis in patients with lung cancer.
- Dosimetric and clinical predictors for radiation-induced esophageal injury.
- Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer?
- A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer.
- Risk of long-term complications after TFG-beta1-guided very-high-dose thoracic radiotherapy.
- Routine use of approximately 60 Gy once-daily thoracic irradiation for patients with limited-stage small-cell lung cancer.
- Optimization of a 90Sr/90Y radiation source train stepping for intravascular brachytherapy.
- Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury.
- Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed ...
- Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalatio...
- A phase I study of dose-dense topotecan given upfront to standard therapy in patients with small cell lung cancer.
- Dose-dependent effects of radiation therapy on cerebral blood flow, metabolism, and neurocognitive dysfunction.
- The impact of pre-radiotherapy surgery on radiation-induced lung injury.
- Long-term changes in pulmonary function tests after definitive radiotherapy for lung cancer.
- Selective inhibition of spermidine biosynthesis and differentiation by S-adenosyl-1,8-diamino-3-thiooctane in murine erythroleukemia cells.
- Modulation of cyclic AMP levels and differentiation by adenosine analogs in mouse erythroleukemia cells.
- Tiazofurin induction of mouse erythroleukemia cell hemoglobin production in the absence of commitment or changes in protooncogene expression.
- Inhibitory effects of theophylline and dibutyryl cAMP on murine erythroleukemia cell differentiation.
- Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
- Inhibition of murine erythroleukemia cell differentiation by 3-deazaadenosine.
- Requirement of spermidine for induction of both heme synthesis and globin transcription in murine erythroleukemia cells.
- Defective induction of stress-activated protein kinase activity in ataxia-telangiectasia cells exposed to ionizing radiation.
- Ionizing radiation stimulates a Grb2-mediated association of the stress-activated protein kinase with phosphatidylinositol 3-kinase.
- Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents.
- Activation of the pp90rsk and mitogen-activated serine/threonine protein kinases by ionizing radiation.
- Coinduction of c-jun gene expression and internucleosomal DNA fragmentation by ionizing radiation.
- Interaction between ATM protein and c-Abl in response to DNA damage.
- Novel radiation technologies for malignant gliomas.
- Heterozygous germline ATM mutations do not contribute to radiation-associated malignancies after Hodgkin's disease.
- Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor.
- Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas.
- Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones.
- Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: a preliminary report of a phase I dose escalat...
- Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation.
- Relating radiation-induced regional lung injury to changes in pulmonary function tests.
- Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer.
- Clear cell pleomorphic xanthoastrocytoma: case report.
- The time course of radiation therapy-induced reductions in regional perfusion: a prospective study with >5 years of follow-up.
Schools
Harvard Medical School
Brigham and Women39s Hospital
Joint Center For Radiation Therapy
Joint Center Radiation Therapy
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Beth Israel Deaconess Medical Center -
Harvard Medical School
Hospital
-
Duke University Hospital
Drug Facts
| NPI NUMBER | 1366424533 | |
| NPPES Provider LastName | SHAFMAN | |
| NPPES Provider FirstName | TIMOTHY | |
| NPPES Provider ZIPCode | 028954705 | |
| NPPES Provider State | RI | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 120.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1366424533 |
| Last Name Of The Provider | SHAFMAN |
| First Name Of The Provider | TIMOTHY |
| View All |
Similar Doctors
|
|
Dr. Rashmi C. Chobe, MD |
|
|
Dr. Tak-Po A. Yu, MD |
|
|
Dr. Mohit S. Kasibhatla, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Vinubhai Patel, MB CHB
This Doctor is OpenDoctor Recommended.
|